The Novel Tubulin Polymerization Inhibitor MHPT Exhibits Selective Anti-Tumor Activity against Rhabdomyosarcoma In Vitro and In Vivo
Cited by 15
Related Papers
Synergistic action by multi-targeting compounds produces a potent compound combination for human NSCLC both in vitro and in vivo
|Cell Death and Disease|2014|17
P-Glycoprotein-Evading Anti-tumor Activity of a Novel Tubulin and HSP90 Dual Inhibitor in a Non-small-cell Lung Cancer Model
|Journal of Pharmacological Sciences|2014|14